MENU
ALLK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Allakos (ALLK) Ownership - Who owns Allakos?

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases... Show more

Profile

Industry
Pharmaceuticals Major
Address
825 Industrial Road
Phone
+1 650 597-5002
Employees
131
Web
https://www.allakos.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
29.74M
P/E Ratio
N/A
Total Cash
55.24M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.45
Dividend Yield
N/A
Total Cash/Share
0.61
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of antibody therapeutics for allergic and inflammatory diseases

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
825 Industrial Road
Phone
+1 650 597-5002
Employees
131
Web
https://www.allakos.com